FMRI-neurofeedback in Depression
RecruitingNCT05640089Phase: NAStarted 2023-01-25
Summary
Previous studies with fMRI-neurofeedback in depression have demonstrated a good safety profile and considerable symptom reduction. The goal of this clinical trial is to compare fMRI-neurofeedback plus
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Mondriaan ZorggroepMaastricht, Netherlands
Maastricht UniversityMaastricht, Netherlands
Maastricht UMC+Maastricht, Netherlands
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05640089